EMBO Molecular Medicine (EMM) is a scholarly journal dedicated to publishing research in the field of Biochemistry Genetics and Molecular Biology, and Published by Wiley Blackwell. The Print-ISSN of EMBO Molecular Medicine is 1757-4676 and its abbreviation is EMBO Mol Med.
The latest Impact Factor of the EMBO Molecular Medicine for 2026-2027 is 11.1.
The Publication fees (APC) is 6,490 EUR, 6,890 USD, 5,590 GBP.
EMBO Molecular MedicineΒ is an open access journal in the field of experimental medicine, dedicated to science at the interface between clinical research and basic life sciences. In addition to human data, we welcome original studies performed in cells and/or animals provided they demonstrate human disease relevance.
| Journal title | EMBO Molecular Medicine (EMM) |
| Abbreviation | EMBO Mol Med |
| Print ISSN | 1757-4676 |
| Online ISSN | 1757-4684 |
| Publisher Name | Wiley Blackwell |
| Editor-in-chief | Philippe Sansonetti |
| Subject Category | Biochemistry Genetics and Molecular Biology |
| Access type | π’ Open Access |
| Status | π’ Active |
In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.
Below are the metrics and rankings for the journal EMBO Molecular Medicine
| Impact Factor | 11.1 |
| SJR | 3.932 |
| SNIP | 1.957 |
| Ranking | 389 |
| CiteScore | 18.3 |
| H-Index | 130 |
| Quartile | Q1 |
| Article Publication Charges (APC) |
6,490 EUR, 6,890 USD, 5,590 GBP β³οΈWithout APC Biochemistry Genetics and Molecular Biology Journals |
Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars
| Abstracting and Indexing |
If you would like to submit a manuscript or visit the journal's website, please click on the link below.
| Journal Submission | π Journal Website |
Add the app to your device for one-tap access.